Skip to main content
. 2014 Dec 1;9(12):e113248. doi: 10.1371/journal.pone.0113248

Table 1. Peptide array sample groups.

Surface reactivity to FCR3S1.2 (MFI) ELISA reactivity to NTS-DBL1α (It4var60) (OD) Rosette Disruption in FCR3S1.2 (%)
NR_CBS08 88.125 0.96 0.00
NR_CBM20 30.6 1.47 4.42
NR_CBM31 109.725 1.25 8.99
NR_CBS35 111.45 1.20 7.78
NR_CBS47 6.5 0.75 7.8
NR_CBS60 12.7 0.76 7.59
NR_CBS89 4.4 0.95 4.2
NR_CBS91 5.5 0.44 8.45
NR_CBM75 185.385 1.22 10.57
NR_CBM77 87.06 1.03 0.62
NR_CBS88 119.08 0.48 11.63
NR_CBM46 189.515 0.77 9.26
NR_CBS162 85.62 1.24 5.94
NR_BUR04 4.07 0.00 8.37
NR_BUR10 125.45 0.18 0.00
NR_BUR11 14.70 0.00 6.26
NR_BUR03 27.71 0.00 13.61
RD_CBM36 306.13 1.73 93.08
RD_CBM41 352.39 1.30 51.97
RD_CBM43 283.81 1.07 20.35
RD_CBM54 222 1.09 16.79
RD_CBM68 336.45 1.45 66.44
RD_CBS155 5.495 1.07 25.83
RD_CBS168 8.895 1.08 19.02
RD_BUR07 5.47 0.42 35.66
RD_BUR08 5.84 1.08 21.38

Summary of the subset of samples further analyzed on the peptide array (shown as red dots in Figure 1C). The table summarizes the sample name (NR: non rosette disruptive; RD: rosette disruptive), surface reactivity towards FCR3S1.2 iRBC (MFI), the ELISA reactivity towards the NTS-DBL1α domain and ability to disrupt the FCR3S1.2 iRBCs rosettes.